Thyroid (Neoplasia)

Cost-effective management of thyroid nodules and nodular thyroid goiters.
[12005008] South Med J 95(5): 514-9 (2002)

Oxyphil cell neoplasms of the thyroid gland.
[8351555] South Med J 86(8): 919-23 (1993)

Iodine 131 metaiodobenzylguanidine scintigraphy of medullary carcinoma of the thyroid.
[1852077] South Med J 84(5): 636-41 (1991)

Carcinoma of the thyroid: review of 304 cases.
[3296227] South Med J 80(6): 741-52 (1987)

Problems in the management of solitary nodules and diffuse goitres.
[9816347] J R Soc Med 91 Suppl 33(-): 17-20 (1998)

Axitinib: The evidence of its potential in the treatment of advanced thyroid cancer.
[20694064] Core Evid 4(-): 43-8 (2010)

Complication of thyroidectomy in patients with radiation-induced thyroid neoplasms.
[15545564] Arch Surg 139(11): 1185-8 (2004)

Medullary thyroid carcinoma--update and present management controversies.
[17002842] Ann R Coll Surg Engl 88(5): 433-8 (2006)

Extent of surgery affects survival for papillary thyroid cancer.
[17717441] Ann Surg 246(3): 375-81; discussion 381-4 (2007)

Staging systems for papillary thyroid carcinoma: a review and comparison.
[17435543] Ann Surg 245(3): 366-78 (2007)

Follicular thyroid carcinoma: the role of histology and staging systems in predicting survival.
[16244545] Ann Surg 242(5): 708-15 (2005)

Insular and anaplastic carcinoma of the thyroid: a 45-year comparative study at a single institution and a review of the significance of p53 and p21.
[10714625] Ann Surg 231(3): 329-38 (2000)

Surgical strategy for the treatment of medullary thyroid carcinoma.
[10561095] Ann Surg 230(5): 697-707 (1999)

Management of carcinoma of the thyroid.
[319768] Ann Surg 185(2): 133-44 (1977)

Cancer of the thyroid: review of 109 cases.
[5445662] Ann Surg 171(5): 735-45 (1970)

The dependency of thyroid cancer; a review.
[13488366] Ann Surg 146(6): 879-91 (1957)

Management of Thyroid nodules in adult patients.
[20444279] Head Neck Oncol 2(-): 11 (2010)

Targeted therapies in thyroid cancer.
[19904500] Target Oncol 4(4): 275-85 (2009)

Differentiated thyroid cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.
[18456786] Ann Oncol 19 Suppl 2(-): ii99-101 (2008)

Current diagnosis and management of medullary thyroid carcinoma.
[9739433] Ann Oncol 9(7): 695-701 (1998)

Anaplastic carcinoma of the thyroid.
[8905033] Ann Oncol 7(7): 739-44 (1996)

Changing concepts in the pathogenesis and management of thyroid carcinoma.
[8806393] CA Cancer J Clin 46(5): 261-83 (1996)

Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma.
[18484584] Cancer 113(1): 48-56 (2008)

Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis.
[17705176] Cancer 110(7): 1451-6 (2007)

Prognosis of medullary thyroid carcinoma: demographic, clinical, and pathologic predictors of survival in 1252 cases.
[17019736] Cancer 107(9): 2134-42 (2006)

Clinical outcome of anaplastic thyroid carcinoma treated with radiotherapy of once- and twice-daily fractionation regimens.
[16967442] Cancer 107(8): 1786-92 (2006)

Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity.
[16900519] Cancer 107(6): 1255-64 (2006)

Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients.
[16470605] Cancer 106(6): 1286-95 (2006)

Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations.
[15880523] Cancer 103(11): 2261-8 (2005)

Prognostic significance of histologic grading compared with subclassification of papillary thyroid carcinoma.
[10760768] Cancer 88(8): 1902-8 (2000)

A spectrum of cytomorphologic variations in medullary thyroid carcinoma. Fine-needle aspiration findings in 19 cases.
[9100540] Cancer 81(1): 40-4 (1997)

Poorly differentiated and anaplastic thyroid cancer.
[16735986] Cancer Control 13(2): 119-28 (2006)

Genetic considerations in thyroid cancer.
[16735985] Cancer Control 13(2): 111-8 (2006)

Familial nonmedullary thyroid carcinoma.
[16735984] Cancer Control 13(2): 106-10 (2006)

Workup of well-differentiated thyroid carcinoma.
[16735983] Cancer Control 13(2): 99-105 (2006)

Evaluation of the thyroid nodule.
[16735982] Cancer Control 13(2): 89-98 (2006)

Tumors of the thyroid gland: histologic and cytologic features--part 2.
[10895133] Cancer Control 7(4): 377-85 (2000)

Tumors of the thyroid gland: histologic and cytologic features--part 1.
[10832114] Cancer Control 7(3): 276-87 (2000)

Medullary carcinoma of the thyroid.
[10832112] Cancer Control 7(3): 253-61 (2000)

Thyroid cancer: extent of thyroidectomy.
[10832110] Cancer Control 7(3): 240-5 (2000)

Prognostic indicators in differentiated thyroid carcinoma.
[10832109] Cancer Control 7(3): 229-39 (2000)

Evaluation of the thyroid nodule.
[10832108] Cancer Control 7(3): 223-8 (2000)

Management of the solitary thyroid nodule.
[18305054] Oncologist 13(2): 105-12 (2008)

Methylation status of genes in papillary thyroid carcinoma.
[17938324] Arch Otolaryngol Head Neck Surg 133(10): 1006-11 (2007)

The importance of central compartment elective lymph node excision in the staging and treatment of papillary thyroid cancer.
[16785411] Arch Otolaryngol Head Neck Surg 132(6): 650-4 (2006)

The C cells (parafollicular cells) of the thyroid gland and medullary thyroid carcinoma. A review.
[18012] Am J Pathol 88(1): 213-50 (1977)

Prognostic factors and therapeutic strategies for differentiated carcinomas of the thyroid.
[18703852] Endocr J 56(2): 177-92 (2009)

Trefoil factor 3 (TFF3): a promising indicator for diagnosing thyroid follicular carcinoma.
[18506086] Endocr J 56(1): 9-16 (2009)

Follicular thyroid carcinoma: From diagnosis to treatment.
[16807500] Endocr J 53(4): 441-8 (2006)

New therapeutic advances in the management of progressive thyroid cancer.
[19218279] Endocr Relat Cancer 16(3): 715-31 (2009)

Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies.
[18987168] Endocr Relat Cancer 16(1): 17-44 (2009)

The genetic basis of hereditary medullary thyroid cancer: clinical implications for the surgeon, with a particular emphasis on the role of prophylactic thyroidectomy.
[19015274] Endocr Relat Cancer 15(4): 871-84 (2008)

New insights in thyroid follicular cell biology and its impact in thyroid cancer therapy.
[18045949] Endocr Relat Cancer 14(4): 957-77 (2007)

Staging systems for follicular thyroid carcinoma: application to 171 consecutive patients treated in a tertiary referral centre.
[17395973] Endocr Relat Cancer 14(1): 29-42 (2007)

Pathogenesis, diagnosis and management of thyroid nodules in children.
[16728572] Endocr Relat Cancer 13(2): 427-53 (2006)

Medullary and papillary carcinoma of the thyroid gland occurring as a collision tumour: report of three cases with molecular analysis and review of the literature.
[15947103] Endocr Relat Cancer 12(2): 281-9 (2005)

BRAF mutation in thyroid cancer.
[15947100] Endocr Relat Cancer 12(2): 245-62 (2005)

Controversies in the follow-up and management of well-differentiated thyroid cancer.
[15027888] Endocr Relat Cancer 11(1): 97-116 (2004)

Management of papillary and follicular (differentiated) thyroid cancer: new paradigms using recombinant human thyrotropin.
[12542401] Endocr Relat Cancer 9(4): 227-47 (2002)

Treatment of medullary thyroid carcinoma: an update.
[11397669] Endocr Relat Cancer 8(2): 135-47 (2001)

Thyroid nodules: a review of current guidelines, practices, and prospects.
[18728120] Eur J Endocrinol 159(5): 493-505 (2008)

European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium.
[16728537] Eur J Endocrinol 154(6): 787-803 (2006)

Post-surgical use of radioiodine (131I) in patients with papillary and follicular thyroid cancer and the issue of remnant ablation: a consensus report.
[16260423] Eur J Endocrinol 153(5): 651-9 (2005)

Fluor-18-deoxyglucose positron emission tomography in differentiated thyroid cancer.
[9625358] Eur J Endocrinol 138(5): 492-6 (1998)

Perspectives for improved and more accurate classification of thyroid epithelial tumors.
[18593772] J Clin Endocrinol Metab 93(9): 3286-94 (2008)

Approach to the patient with a positive serum thyroglobulin and a negative radioiodine scan after initial therapy for differentiated thyroid cancer.
[18463349] J Clin Endocrinol Metab 93(5): 1519-25 (2008)

Associations of serum thyrotropin concentrations with recurrence and death in differentiated thyroid cancer.
[17426094] J Clin Endocrinol Metab 92(7): 2610-5 (2007)

131I activity for remnant ablation in patients with differentiated thyroid cancer: A systematic review.
[17032718] J Clin Endocrinol Metab 92(1): 28-38 (2007)

Ambiguous thyroglobulin assay results in the follow-up of differentiated thyroid carcinoma.
[16207895] J Clin Endocrinol Metab 90(10): 5904-5 (2005)

Statins sentence thyroid cancer cells to death rho.
[12843137] J Clin Endocrinol Metab 88(7): 3019-20 (2003)

Clinical review 158: Beyond radioiodine: a review of potential new therapeutic approaches for thyroid cancer.
[12727938] J Clin Endocrinol Metab 88(5): 1947-60 (2003)

Clinical review 156: Recombinant human thyrotropin and thyroid cancer management.
[12727936] J Clin Endocrinol Metab 88(5): 1933-8 (2003)

A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma.
[12679418] J Clin Endocrinol Metab 88(4): 1433-41 (2003)

Effectiveness of thyroid hormone suppressive therapy in benign solitary thyroid nodules: a meta-analysis.
[12213864] J Clin Endocrinol Metab 87(9): 4154-9 (2002)

Optimizing the outcomes of adjuvant radioiodine therapy in differentiated thyroid carcinoma.
[12213844] J Clin Endocrinol Metab 87(9): 4059-62 (2002)

The genetics of hereditary nonmedullary thyroid carcinoma.
[12050199] J Clin Endocrinol Metab 87(6): 2455-9 (2002)

Using baseline and recombinant human TSH-stimulated Tg measurements to manage thyroid cancer without diagnostic (131)I scanning.
[11932269] J Clin Endocrinol Metab 87(4): 1486-9 (2002)

Diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography in the follow-up of papillary or follicular thyroid cancer.
[11502811] J Clin Endocrinol Metab 86(8): 3779-86 (2001)

Clinical review 133: Progress in understanding the etiology of thyroid autonomy.
[11443209] J Clin Endocrinol Metab 86(7): 3336-45 (2001)

Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer.
[11297567] J Clin Endocrinol Metab 86(4): 1447-63 (2001)

The use of radioactive iodine in patients with papillary and follicular thyroid cancer.
[9851751] J Clin Endocrinol Metab 83(12): 4195-203 (1998)

The diagnosis of recurrent thyroid cancer--a new approach.
[9851749] J Clin Endocrinol Metab 83(12): 4189-90 (1998)

Suppressive therapy with levothyroxine for solitary thyroid nodules: a double-blind controlled clinical study and cumulative meta-analyses.
[9814462] J Clin Endocrinol Metab 83(11): 3881-5 (1998)

Effect of early referral to an endocrinologist on efficiency and cost of evaluation and development of treatment plan in patients with thyroid nodules.
[9814450] J Clin Endocrinol Metab 83(11): 3803-7 (1998)

Surgical management of pituitary tumors.
[9253304] J Clin Endocrinol Metab 82(8): 2381-5 (1997)

MIBG for diagnosis and therapy of medullary thyroid carcinoma: is there still a role?
[19088696] Q J Nucl Med Mol Imaging 52(4): 430-40 (2008)

Prevalence of asthma in a large group of Israeli adolescents: influence of country of birth and age at migration.
[18384451] Allergy 63(8): 1040-5 (2008)

A case of stunning of lung and bone metastases of papillary thyroid cancer after a therapeutic dose (3.7 GBq) of 131I and review of the literature: implications for sequential treatments.
[15845937] Br J Radiol 78(929): 428-32 (2005)

Review: Medullary carcinoma of the thyroid: radiographic features of a unique tumor.
[7046403] AJR Am J Roentgenol 139(1): 149-55 (1982)

Treatment of thyroid carcinoma: emphasis on high-dose 131I outpatient therapy.
[12446749] J Nucl Med Technol 30(4): 165-71; quiz 172-3 (2002)

Thyroid reports: insight into radioiodine ablation and new guidelines for nodule management.
[16594104] J Nucl Med 47(3): 15N, 26N (2006)

Empirically treating high serum thyroglobulin levels.
[16000275] J Nucl Med 46(7): 1079-88 (2005)

The evolving role of (131)I for the treatment of differentiated thyroid carcinoma.
[15653649] J Nucl Med 46 Suppl 1(-): 28S-37S (2005)

Sodium iodide symporter: its role in nuclear medicine.
[12215558] J Nucl Med 43(9): 1188-200 (2002)

Procedure guideline for therapy of thyroid disease with (131)iodine.
[12050333] J Nucl Med 43(6): 856-61 (2002)

Uptake of (201)Tl into primary cell cultures from human thyroid tissue is multiplied by TSH.
[11850477] J Nucl Med 43(2): 145-52 (2002)

Thyroid carcinoma with high levels of function: treatment with (131)I.
[11390565] J Nucl Med 42(6): 975-83 (2001)

Therapeutic 131I in outpatients: a simplified method conforming to the Code of Federal Regulations, title 10, part 35.75.
[11079497] J Nucl Med 41(11): 1868-75 (2000)

Evaluation of the thyroid nodule.
[1658255] J Nucl Med 32(11): 2181-92 (1991)

Endocrine imaging in the management of goiter and thyroid nodules: Part I.
[2066807] J Nucl Med 32(7): 1455-61 (1991)

The autonomously functioning thyroid nodule.
[1988633] J Nucl Med 32(1): 30-2 (1991)

US Features of thyroid malignancy: pearls and pitfalls.
[17495296] Radiographics 27(3): 847-60; discussion 861-5 (2007)

Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
[20555084] Ann Oncol 21 Suppl 5(-): v214-9 (2010)

Differentiated thyroid cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.
[19454437] Ann Oncol 20 Suppl 4(-): 143-6 (2009)

Complications of neck dissection for thyroid cancer.
[18058179] Ann Surg Oncol 15(2): 397-9 (2008)

Incidental thyroid nodules on chest CT: Review of the literature and management suggestions.
[20966308] AJR Am J Roentgenol 195(5): 1066-71 (2010)

The Bethesda System For Reporting Thyroid Cytopathology.
[19846805] Am J Clin Pathol 132(5): 658-65 (2009)

Thyroid cytology comes to Bethesda.
[19846804] Am J Clin Pathol 132(5): 655-7 (2009)

Molecular rearrangements and morphology in thyroid cancer.
[12057897] Am J Pathol 160(6): 1941-4 (2002)

Postoperative surveillance of differentiated thyroid carcinoma: rationale, techniques, and controversies.
[18936309] Radiology 249(2): 429-44 (2008)

Benign and malignant thyroid nodules: US differentiation--multicenter retrospective study.
[18403624] Radiology 247(3): 762-70 (2008)

Approach to the thyroid cancer patient with extracervical metastases.
[20203334] J Clin Endocrinol Metab 95(3): 987-93 (2010)

Selectively targeting mutant BRAF in thyroid cancer.
[20056810] J Clin Endocrinol Metab 95(1): 60-1 (2010)

Advances in chemotherapy of differentiated epithelial and medullary thyroid cancers.
[19258410] J Clin Endocrinol Metab 94(5): 1493-9 (2009)

Calcitonin measurement in the evaluation of thyroid nodules in the United States: a cost-effectiveness and decision analysis.
[18364376] J Clin Endocrinol Metab 93(6): 2173-80 (2008)

Current status of molecularly targeted drugs for the treatment of advanced thyroid cancer.
[21383525] Endocr J 58(3): 151-3 (2011)

Medullary thyroid cancer: monitoring and therapy.
[17673130] Endocrinol Metab Clin North Am 36(3): 823-37, viii (2007)

RET/PTC rearrangement in benign and malignant thyroid diseases: a clinical standpoint.
[21750045] Eur J Endocrinol 165(4): 499-507 (2011)

Targeting the RET pathway in thyroid cancer.
[19934298] Clin Cancer Res 15(23): 7119-23 (2009)

Standard and emerging therapies for metastatic differentiated thyroid cancer.
[20142332] Oncologist 15(2): 146-56 (2010)

Genetic aspects of familial thyroid cancer.
[19465682] Oncologist 14(6): 571-7 (2009)

Papillary microcarcinoma of the thyroid among atomic bomb survivors: tumor characteristics and radiation risk.
[20120034] Cancer 116(7): 1646-55 (2010)

NA cohort study of thyroid cancer and other thyroid diseases after the Chernobyl accident: cytohistopathologic correlation and accuracy of fine-needle aspiration biopsy in nodules detected during the first screening in Ukraine (1998-2000).
[19365829] Cancer 117(2): 73-81 (2009)

Targeting BRAF in thyroid cancer.
[17179987] Br J Cancer 96(1): 16-20 (2007)

Detection of the PAX8-PPARgamma fusion protein in thyroid tumors.
[20075182] Clin Chem 56(3): 331-3 (2010)

Targeted molecular therapies in thyroid carcinoma.
[20126863] Arq Bras Endocrinol Metabol 53(9): 1061-73 (2009)

Thyroid spindle epithelial tumor with thymus-like differentiation (SETTLE): case report and review.
[21085772] Arq Bras Endocrinol Metabol 54(7): 657-62 (2010)

Childhood thyroid cancer in Belarus, Russia, and Ukraine after Chernobyl and at present.
[17891238] Arq Bras Endocrinol Metabol 51(5): 748-62 (2007)

PET imaging in differentiated thyroid cancer: where does it fit and how do we use it?
[17891243] Arq Bras Endocrinol Metabol 51(5): 793-805 (2007)

The importance of sodium/iodide symporter (NIS) for thyroid cancer management.
[17891230] Arq Bras Endocrinol Metabol 51(5): 672-82 (2007)

20 years of RET/PTC in thyroid cancer: clinico-pathological correlations.
[17891236] Arq Bras Endocrinol Metabol 51(5): 731-5 (2007)

New perspectives on the treatment of differentiated thyroid cancer.
[17684624] Arq Bras Endocrinol Metabol 51(4): 612-24 (2007)

6: Thyroid nodules and thyroid cancer.
[14984346] Med J Aust 180(5): 242-7 (2004)

Well differentiated thyroid cancer.
[15658666] Scand J Surg 93(4): 261-71 (2004)

Anaplastic giant cell thyroid carcinoma.
[15658667] Scand J Surg 93(4): 272-7 (2004)

Benign multinodular goiter.
[15658668] Scand J Surg 93(4): 278-81 (2004)

Ultrasound of thyroid cancer.
[16361145] Cancer Imaging 5(-): 157-66 (2005)

Imaging for staging and management of thyroid cancer.
[18390389] Cancer Imaging 8(-): 57-69 (2008)

A risk-adapted approach to the use of radioactive iodine and external beam radiation in the treatment of well-differentiated thyroid cancer.
[21451451] Cancer Control 18(2): 89-95 (2011)

New treatments and shifting paradigms in differentiated thyroid cancer management.
[21451452] Cancer Control 18(2): 96-103 (2011)

Nuclear medicine in diagnosis, staging and follow-up of thyroid cancer.
[15243406] Q J Nucl Med Mol Imaging 48(2): 82-95 (2004)

The role of (124)I-PET in diagnosis and treatment of thyroid carcinoma.
[17657202] Q J Nucl Med Mol Imaging 52(1): 30-6 (2008)

Targeted therapy in radioiodine refractory thyroid cancer.
[19910905] Q J Nucl Med Mol Imaging 53(5): 520-5 (2009)

Recombinant human TSH (rhTSH) in 2009: new perspectives in diagnosis and therapy.
[19910902] Q J Nucl Med Mol Imaging 53(5): 490-502 (2009)

Serum thyroglobulin measurement in the follow-up of patients treated for differentiated thyroid cancer.
[19910901] Q J Nucl Med Mol Imaging 53(5): 482-9 (2009)

Radioiodine ablation: when and how.
[19910900] Q J Nucl Med Mol Imaging 53(5): 473-81 (2009)

Update on the diagnosis and treatment of differentiated thyroid cancer.
[19910899] Q J Nucl Med Mol Imaging 53(5): 465-72 (2009)

Potential value of elastosonography in the diagnosis of malignancy in thyroid nodules.
[19910898] Q J Nucl Med Mol Imaging 53(5): 455-64 (2009)

Molecular pathology of differentiated thyroid cancer.
[19910897] Q J Nucl Med Mol Imaging 53(5): 440-53 (2009)

The role of the PAX8/PPARgamma fusion oncogene in the pathogenesis of follicular thyroid cancer.
[19883731] Mol Cell Endocrinol 321(1): 50-6 (2010)

The PI3K-Akt-mTOR pathway in initiation and progression of thyroid tumors.
[19897009] Mol Cell Endocrinol 321(1): 20-8 (2010)

Mechanisms of chromosomal rearrangements in solid tumors: the model of papillary thyroid carcinoma.
[19766698] Mol Cell Endocrinol 321(1): 36-43 (2010)

My approach to oncocytic tumours of the thyroid.
[14990587] J Clin Pathol 57(3): 225-32 (2004)

Our approach to follicular-patterned lesions of the thyroid.
[16798933] J Clin Pathol 60(3): 244-50 (2007)

Thyroid carcinoma: molecular pathways and therapeutic targets.
[18437172] Mod Pathol 21 Suppl 2(-): S37-43 (2008)

The FOXE1 locus is a major genetic determinant for radiation-related thyroid carcinoma in Chernobyl.
[20350937] Hum Mol Genet 19(12): 2516-23 (2010)

Expression and function of the novel proto-oncogene PBF in thyroid cancer: a new target for augmenting radioiodine uptake.
[21450804] J Endocrinol 210(2): 157-63 (2011)

Thyroid stem cells: lessons from normal development and thyroid cancer.
[18310275] Endocr Relat Cancer 15(1): 51-8 (2008)

RET oncogene in MEN2, MEN2B, MTC and other forms of thyroid cancer.
[18402529] Expert Rev Anticancer Ther 8(4): 625-32 (2008)

Interleukin 24 is induced by the RET/PTC3 oncoprotein and is an autocrine growth factor for epithelial cells.
[15326486] Oncogene 23(45): 7571-9 (2004)

Conservative management of well-differentiated thyroid cancer.
[20334743] Can J Surg 53(2): 109-18 (2010)

The role of prophylactic central neck dissection in differentiated thyroid carcinoma: issues and controversies.
[21977029] J Oncol 2011(-): 127929 (2011)

Thyroid Nodules in Children: A Single Institution's Experience.
[22007213] J Oncol 2011(-): 974125 (2011)

Thyroid cancer: current molecular perspectives.
[20369062] J Oncol 2010(-): 351679 (2010)

New agents in the treatment for malignancies of the salivary and thyroid glands.
[19010274] Hematol Oncol Clin North Am 22(6): 1279-95, xi (2008)

Recent advances in molecular biology of thyroid cancer and their clinical implications.
[19040974] Otolaryngol Clin North Am 41(6): 1135-46, ix (2008)

Invasive thyroid cancer: management of the trachea and esophagus.
[19040976] Otolaryngol Clin North Am 41(6): 1155-68, ix-x (2008)

Review of atypical cytology of thyroid nodule according to the Bethesda system and its beneficial effect in the surgical treatment of papillary carcinoma.
[22066105] J Korean Surg Soc 81(2): 75-84 (2011)

A Controlled Vocabulary to Represent Sonographic Features of the Thyroid and its application in a Bayesian Network to Predict Thyroid Nodule Malignancy.
[21347173] Summit on Translat Bioinforma 2009(-): 68-72 (2009)

Clinical implications of molecular studies for the diagnosis of thyroid cancer.
[20363721] Hormones (Athens) 9(1): 51-6 (2010)

Thyroid cancer in childhood: management strategy, including dosimetry and long-term results.
[18055418] Hormones (Athens) 6(4): 269-78 (2007)

Thyroid nodules - stepwise diagnosis and management.
[17704042] Hormones (Athens) 6(2): 101-19 (2007)

The Putative PAX8/PPARγ Fusion Oncoprotein Exhibits Partial Tumor Suppressor Activity through Up-Regulation of Micro-RNA-122 and Dominant-Negative PPARγ Activity.
[21779480] Genes Cancer 2(1): 46-55 (2011)

Epigenetics of thyroid cancer and novel therapeutic targets.
[21325372] J Mol Endocrinol 46(3): R73-81 (2011)

Thyroid hormone receptor mutations in cancer and resistance to thyroid hormone: perspective and prognosis.
[21760978] J Thyroid Res 2011(-): 361304 (2011)

Thyroid carcinoma in children and adolescents-systematic review of the literature.
[21904689] J Thyroid Res 2011(-): 845362 (2011)

Old and new insights in the treatment of thyroid carcinoma.
[21048836] J Thyroid Res 2010(-): 279468 (2010)

Factors determining the persistence or recurrence of well-differentiated thyroid cancer treated by thyroidectomy and/or radioiodine in the Boston, Massachusetts area: A retrospective chart review.
[21496269] Thyroid Res 4(1): 9 (2011)

Lessons from mouse models of thyroid cancer.
[20001715] Thyroid 19(12): 1317-31 (2009)

Potential utility and limitations of thyroid cancer cell lines as models for studying thyroid cancer.
[20001716] Thyroid 19(12): 1333-42 (2009)

Chest CT incidentalomas: thyroid lesions, enlarged mediastinal lymph nodes, and lung nodules.
[22391408] Cancer Imaging 12():41-8 (2012)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Thyroid (Neoplasia).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Thyroid (Neoplasia).php on line 92